Bronchodilator response to nebulized salbutamol in elderly patients with stable chronic airflow limitation.

Abstract	The bronchodilator response to 5 mg nebulized salbutamol was studied in 20 elderly patients with stable chronic airflow limitation. Salbutamol produced significantly greater increases in FEV1 and FVC compared with placebo although there was no difference in subjective sensation of breathlessness. Spirometry can be successfully used to assess respiratory function in appropriately selected elderly patients with chronic airflow limitation.
Authors	R Geraghty, C Foster, D Black, S Roe
Journal	Respiratory medicine (Respir Med) Vol. 87 Issue 5 Pg. 375-8 (Jul 1993) ISSN: 0954-6111 [Print] England
PMID	8209057 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References	Aerosols Albuterol
Topics	Aerosols Aged Albuterol (administration & dosage, therapeutic use) Bronchi (drug effects, physiology) Double-Blind Method Female Forced Expiratory Volume (drug effects) Humans Lung Diseases, Obstructive (drug therapy, physiopathology) Male Spirometry Vital Capacity (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!